The contribution of familial and heritable risks in heart failure

Current Opinion in Cardiology

Volumn 22, Issue 3, 2007, Pages 214-219

  Abdel Qadir, Husam M ^a   Lee, Douglas S ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Family history; Genetics; Heart failure; Prevention; Risk factors

Indexed keywords

CARDIOVASCULAR RISK; GENE LOCUS; GENETIC DISORDER; HEART DISEASE; HEART FAILURE; HERITABILITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; METABOLIC DISORDER; MONOGENIC DISORDER; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROGENY; QUANTITATIVE TRAIT LOCUS; REVIEW; RISK FACTOR; VALVULAR HEART DISEASE;

GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART FAILURE, CONGESTIVE; HUMANS; INSULIN RESISTANCE; OBESITY; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS;

EID: 34147195487     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3280d9e855     Document Type: Review

References (93)

1. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85-e151.
2. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106:3068-3072.
3. Ho KK, Anderson KM, Kannel WB, et al. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88:107-115.
4. Chen YT, Vaccarino V, Williams CS, et al. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Med 1999; 106:605-612.
5. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35:1628-1637.
6. Kannel WB, D'Agostino RB, Silbershatz H, et al. Profile for estimating risk of heart failure. Arch Intern Med 1999; 159:1197-1204.
7. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347:305-313.
8. Lee DS, Pencina MJ, Benjamin EJ, et al. Association of parental heart failure with risk of heart failure in offspring. N Engl J Med 2006; 355:138-147. This study demonstrated an increased risk of heart failure and abnormalities of left ventricular structure and function in offspring if at least one parent had heart failure occur before the age of 75 years.
9. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 2005; 45:969-981.
10. Richard P, Villard E, Charron P, Isnard R. The genetic bases of cardiomyopathies. J Am Coll Cardiol 2006; 48:A79-A89. A review article that provides an overview of the genes and loci implicated in the development of various types of cardiomyopathy.
11. Baig MK, Goldman JH, Caforio AL, et al. Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 1998; 31:195-201.
12. Grunig E, Tasman JA, Kucherer H, et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998; 31:186-194.
13. Mestroni L, Rocco C, Gregori D, et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 1999; 34:181-190.
14. Murphy RT, Mogensen J, Shaw A, et al. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 2004; 363:371-372.
15. Suomalainen A, Paetau A, Leinonen H, et al. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 1992; 340:1319-1320.
16. Ingles J, Doolan A, Chiu C, et al. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 2005; 42:e59.
17. Drazner MH, Rame JE, Marino EK, et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol 2004; 43:2207-2215.
18. Vasan RS, Larson MG, Benjamin EJ, et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997; 336:1350-1355.
19. Swan L, Birnie DH, Padmanabhan S, et al. The genetic determination of left ventricular mass in healthy adults. Eur Heart J 2003; 24:577-582.
20. Post WS, Larson MG, Myers RH, et al. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension 1997; 30:1025-1028.
21. Chien KL, Hsu HC, Su TC, et al. Heritability and major gene effects on left ventricular mass in the Chinese population: a family study. BMC Cardiovasc Disord 2006; 6:37.
22. Juo SH, Di Tullio MR, Lin HF, et al. Heritability of left ventricular mass and other morphologic variables in Caribbean Hispanic subjects: the Northern Manhattan Family Study. J Am Coll Cardiol 2005; 46:735-737.
23. Sharma P, Middelberg RP, Andrew T, et al. Heritability of left ventricular mass in a large cohort of twins. J Hypertens 2006; 24:321-324.
24. Morita H, Larson MG, Barr SC, et al. Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation 2006; 113:2697-2705. A community-based study associating mutations in genes implicated in dilated cardiomyopathy with the complex genetic phenotype of left ventricular wall thickness.
25. Jamshidi Y, Montgomery HE, Hense HW, et al. Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation 2002; 105:950-955.
26. Babiker FA, Lips D, Meyer R, et al. Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vasc Biol 2006; 26:1524-1530.
27. Rubattu S, Bigatti G, Evangelista A, et al. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006; 48:499-505.
28. Arnett DK, Hong Y, Bella JN, et al. Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network. Am J Hypertens 2001; 14:1226-1230.
29. Kuznetsova T, Staessen JA, Olszanecka A, et al. Maternal and paternal influences on left ventricular mass of offspring. Hypertension 2003; 41:69-74.
30. Small KM, Wagoner LE, Levin AM, et al. Synergistic polymorphisms of beta1-and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002; 347:1135-1142.
31. Liggett SB, Mialet-Perez J, Thaneemit-Chen S, et al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci U S A 2006; 103:11288-11293.
32. Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330:1041-1046.
33. Zdravkovic S, Wienke A, Pedersen NL, et al. Heritability of death from coronary heart disease: a 36-year follow-up of 20,966 Swedish twins. J Intern Med 2002; 252:247-254.
34. Jousilahti P, Puska P, Vartiainen E, et al. Parental history of premature coronary heart disease: an independent risk factor of myocardial infarction. J Clin Epidemiol 1996; 49:497-503.
35. Sesso HD, Lee IM, Gaziano JM, et al. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation 2001; 104:393-398.
36. Silberberg JS, Wlodarczyk J, Fryer J, et al. Risk associated with various definitions of family history of coronary heart disease. The Newcastle Family History Study II. Am J Epidemiol 1998; 147:1133-1139.
37. Williams RR, Hunt SC, Heiss G, et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol 2001; 87:129-135.
38. Pohjola-Sintonen S, Rissanen A, Liskola P, Luomanmaki K. Family history as a risk factor of coronary heart disease in patients under 60 years of age. Eur Heart J 1998; 19:235-239.
39. Murabito JM, Nam BH, D'Agostino RB Sr, et al. Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med 2004; 140:434-440.
40. Lloyd-Jones DM, Nam BH, D'Agostino RB Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 2004; 291:2204-2211.
41. Murabito JM, Pencina MJ, Nam BH, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 2005; 294:3117-3123.
42. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA. Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J 2006; 152:305-311.
43. Scheuner MT, Whitworth WC, McGruder H, et al. Familial risk assessment for early-onset coronary heart disease. Genet Med 2006; 8:525-531.
44. Fischer M, Broeckel U, Holmer S, et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 2005; 111:855-862.
45. Nasir K, Michos ED, Rumberger JA, et al. Coronary artery calcification and family history of premature coronary heart disease: sibling history is more strongly associated than parental history. Circulation 2004; 110:2150-2156.
46. Kumamoto T, Kawai Y, Arakawa K, et al. Association of Gln222Arg polymorphism in the deoxyribonuclease I (DNase I) gene with myocardial infarction in Japanese patients. Eur Heart J 2006; 27:2081-2087.
47. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002; 287:1003-1010.
48. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA 1996; 275:1557-1562.
49. Hottenga JJ, Whitfield JB, de Geus EJ, et al. Heritability and stability of resting blood pressure in Australian twins. Twin Res Hum Genet 2006; 9:205-209.
50. Bochud M, Bovet P, Elston RC, et al. High heritability of ambulatory blood pressure in families of East African descent. Hypertension 2005; 45:445-450.
51. Hong Y, de Faire U, Heller DA, et al. Genetic and environmental influences on blood pressure in elderly twins. Hypertension 1994; 24:663-670.
52. Wu X, Kan D, Province M, et al. An updated meta-analysis of genome scans for hypertension and blood pressure in the NHLBI Family Blood Pressure Program (FBPP). Am J Hypertens 2006; 19:122-127.
53. Munroe PB, Wallace C, Xue MZ, et al. Increased support for linkage of a novel locus on chromosome 5q13 for essential hypertension in the British Genetics of Hypertension Study. Hypertension 2006; 48:105-111.
54. Chen W, Li S, Srinivasan SR, et al. Autosomal genome scan for loci linked to blood pressure levels and trends since childhood: the Bogalusa Heart Study. Hypertension 2005; 45:954-959.
55. Marteau JB, Zaiou M, Siest G, Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens 2005; 23:2127-2143.
56. Mein CA, Caulfield MJ, Dobson RJ, Munroe PB. Genetics of essential hypertension. Hum Mol Genet 2004; 13:R169-R175.
57. Vaccarino V, Holford TR, Krumholz HM. Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 2000; 36:130-138.
58. Haider AW, Larson MG, Franklin SS, Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138:10-16.
59. Khattar RS, Acharya DU, Kinsey C, et al. Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension. J Hypertens 1997; 15:737-743.
60. Palmieri V, Devereux RB, Hollywood J, et al. Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the Strong Heart Study. Am J Hypertens 2006; 19:601-607.
61. Mitchell GF, DeStefano AL, Larson MG, et al. Heritability and a genome-wide linkage scan for arterial stiffness, wave reflection, and mean arterial pressure: the Framingham Heart Study. Circulation 2005; 112:194-199.
62. DeStefano AL, Larson MG, Mitchell GF, et al. Genome-wide scan for pulse pressure in the National Heart, Lung and Blood Institute's Framingham Heart Study. Hypertension 2004; 44:152-155.
63. Bielinski SJ, Lynch AI, Miller MB, et al. Genome-wide linkage analysis for loci affecting pulse pressure: the Family Blood Pressure Program. Hypertension 2005; 46:1286-1293.
64. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005; 45:1050-1055.
65. Kucerova J, Filipovsky J, Staessen JA, et al. Arterial characteristics in normotensive offspring of parents with or without a history of hypertension. Am J Hypertens 2006; 19:264-269.
66. Dernellis J, Panaretou M. Aortic stiffness in children of parents with hypertension. J Hum Hypertens 2006; 20:225-226.
67. Fava C, Burri P, Almgren P, et al. Dipping and variability of blood pressure and heart rate at night are heritable traits. Am J Hypertens 2005; 18:1402-1407.
68. Ingelsson E, Bjorklund-Bodegard K, Lind L, et al. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 2006; 295:2859-2866.
69. Manunta P, Iacoviello M, Forleo C, et al. High circulating levels of endogenous ouabain in the offspring of hypertensive and normotensive individuals. J Hypertens 2005; 23:1677-1681.
70. Pierdomenico SD, Bucci A, Manunta P, et al. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am J Hypertens 2001; 14:44-50.
71. Nicklas BJ, Cesari M, Penninx BW, et al. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc 2006; 54:413-420.
72. Kaftan HA, Evrengul H, Tanriverdi H, Kilic M. Effect of insulin resistance on left ventricular structural changes in hypertensive patients. Int Heart J 2006; 47:391-400.
73. Ingelsson E, Sundstrom J, Arnlov J, et al. Insulin resistance and risk of congestive heart failure. JAMA 2005; 294:334-341.
74. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115:e290-e296.
75. Wu Q, Suzuki M. Parental obesity and overweight affect the body-fat accumulation in the offspring: the possible effect of a high-fat diet through epigenetic inheritance. Obes Rev 2006; 7:201-208.
76. Butte NF, Cai G, Cole SA, Comuzzie AG. Viva la Familia Study: genetic and environmental contributions to childhood obesity and its comorbidities in the Hispanic population. Am J Clin Nutr 2006; 84:646-654.
77. Walley AJ, Blakemore AI, Froguel P. Genetics of obesity and the prediction of risk for health. Hum Mol Genet 2006; 15:R124-R130.
78. Chien KL, Hsu HC, Chen WJ, et al. Familial aggregation of metabolic syndrome among the Chinese: report from the Chin-Shan community family study. Diabetes Res Clin Pract 2006 (in press).
79. Lin HF, Boden-Albala B, Juo SH, et al. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 2005; 48:2006-2012.
80. Andersen G, Wegner L, Yanagisawa K, et al. Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity. J Med Genet 2005; 42:402-407.
81. Abdollahi MR, Gaunt TR, Syddall HE, et al. Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits. J Med Genet 2005; 42:396-401.
82. Lumiaho A, Ikaheimo R, Miettinen R, et al. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1. Am J Kidney Dis 2001; 38:1208-1216.
83. Trochu JN, Kyndt F, Schott JJ, et al. Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to Xq28. J Am Coll Cardiol 2000; 35:1890-1897.
84. Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet 1999; 65:1242-1251.
85. Kyndt F, Schott JJ, Trochu JN, et al. Mapping of X-linked myxomatousvalvular dystrophy to chromosome Xq28. Am J Hum Genet 1998; 62:627-632.
86. Chou HT, Tsai CH, Tsai FJ. Association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and risk of rheumatic heart disease. Jpn Heart J 2004; 45:949-957.
87. Davutoglu V, Nacak M. Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification. J Heart Valve Dis 2005; 14:277-281.
88. Cripe L, Andelfinger G, Martin LJ, et al. Bicuspid aortic valve is heritable. J Am Coll Cardiol 2004; 44:138-143.
89. Lewin MB, McBride KL, Pignatelli R, et al. Echocardiographic evaluation of asymptomatic parental and sibling cardiovascular anomalies associated with congenital left ventricular outflow tract lesions. Pediatrics 2004; 114:691-696.
90. Probst V, Le Scouarnec S, Legendre A, et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 2006; 113:856-860. A study demonstrating the familial aggregation of calcific aortic valve stenosis in the western region of France.
91. Ortlepp JR, Hoffmann R, Ohme F, et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001; 85:635-638.
92. Novaro GM, Sachar R, Pearce GL, et al. Association between apolipoprotein Ealleles and calcific valvular heart disease. Circulation 2003; 108:1804-1808.
93. Caira FC, Stock SR, Gleason TG, et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 2006; 47:1707-1712.